Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2013-11-25 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MACHECOUL-SAINT-MEME (44270), Loire-Atlantique
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CENTR'HALLES : revenue, balance sheet and financial ratios
PHARMACIE CENTR'HALLES is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MACHECOUL-SAINT-MEME (44270),
this company of category PME
shows in 2024 a net income positive of 160 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CENTR'HALLES (SIREN 798721098)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
159 686 €
179 613 €
320 101 €
319 330 €
225 833 €
135 690 €
198 946 €
178 505 €
185 357 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
Im Jahr 2024 erzielt PHARMACIE CENTR'HALLES ein positives Nettoergebnis von 160 k€. Entwicklung 2016-2024: 185 k€ -> 160 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
159 686 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 117%. Der Verschuldungsgrad ist hoch: Der Verhandlungsspielraum mit Banken ist reduziert. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 43%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
117.366%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
42.539%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
304.1
208.141
142.935
121.753
100.468
66.145
115.698
124.531
117.366
Financial autonomy
22.62
30.079
37.963
42.634
46.527
53.091
41.263
40.795
42.539
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Verschuldungsgrad
117.372024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average+6 pts over 3 years
Im Jahr 2024 liegt über dem Median der Branche das verschuldungsgrad von PHARMACIE CENTR'HALLES (117.37). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Eine Reduzierung könnte die finanzielle Stärke verbessern.
Finanzielle Autonomie
42.54%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
Im Jahr 2024 liegt unter dem Median der Branche das finanzielle autonomie von PHARMACIE CENTR'HALLES (42.5%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Eine Verbesserung würde die Wettbewerbsposition stärken.
Liquidity ratios
Die Liquiditätsquote beträgt 304.26. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
236.9
298.276
293.69
464.639
413.185
267.313
321.514
325.272
304.259
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquiditätsquote
304.262024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Ausgezeichnet
Im Jahr 2024 liegt in den oberen 25% der Branche das liquiditätsquote von PHARMACIE CENTR'HALLES (304.26). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Ein Verhältnis über 1 gewährleistet komfortable Deckung kurzfristiger Fälligkeiten.
Positioning of PHARMACIE CENTR'HALLES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE CENTR'HALLES is estimated at
2 229 334 €
(range 1 552 473€ - 3 335 212€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1552k€2229k€3335k€
2 229 334 €Range: 1 552 473€ - 3 335 212€
NAF 5 année 2024
Valuation method used
Net Income Multiple
159 686 €
×
14.0x
=2 229 335 €
Range: 1 552 473€ - 3 335 212€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CENTR'HALLES with other companies in the same sector:
Frequently asked questions about PHARMACIE CENTR'HALLES
What is the revenue of PHARMACIE CENTR'HALLES ?
The revenue of PHARMACIE CENTR'HALLES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE CENTR'HALLES profitable?
Yes, PHARMACIE CENTR'HALLES generated a net profit of 160 k€ in 2024.
Where is the headquarters of PHARMACIE CENTR'HALLES ?
The headquarters of PHARMACIE CENTR'HALLES is located in MACHECOUL-SAINT-MEME (44270), in the department Loire-Atlantique.
Where to find the tax return of PHARMACIE CENTR'HALLES ?
The tax return of PHARMACIE CENTR'HALLES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CENTR'HALLES operate?
PHARMACIE CENTR'HALLES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart